Daniel Muehl Insider Profile

4 Followers
Daniel Muehl, CFO at Repligen, holds 10.00K shares in Repligen (Ticker: RGEN), holds 104.83K shares in Clovis Oncology (Ticker: CLVSQ). Most recently, Daniel Muehl ― shares of Repligen on ― for an estimated value of ―.
tipranks
Daniel Muehl

Daniel Muehl
Repligen (RGEN)
CFO

Not Ranked
Daniel Muehl has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
A breakdown of Daniel Muehl's holdings

Insider Roles

Repligen
(RGEN)
CFO
Roles that Daniel Muehl holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Daniel Muehl

Daniel Muehl's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Repligen
CFO
$1.46M
CLVSQ
Clovis Oncology
$1.57K
List of latest transactions for each holding click on a transaction to see Daniel Muehl's performance on stock

Daniel Muehl insider profile FAQ

What is the percentage of profitable transactions made by Daniel Muehl?
The percentage of profitable transactions made by Daniel Muehl is ―.
    What is the average return per transaction made by Daniel Muehl?
    The average return per transaction made by Daniel Muehl is ―.
      What stocks does Daniel Muehl hold?
      Daniel Muehl holds: RGEN, CLVSQ stocks.
        What was Daniel Muehl’s latest transaction?
        Daniel Muehl latest transaction was an Uninformative Buy of ―.
          What was Daniel Muehl's most profitable transaction?
          Daniel Muehl’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Daniel Muehl's role in Repligen?
            Daniel Muehl's role in Repligen is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.